Latest news
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 19:00:00 GMTOutcomes in Early-Stage Triple-Negative Breast Cancer With Dose-Dense Doxorubicin and Cyclophosphamide as Part of Pembrolizumab-Based Regimens - Journal of Hematology Oncology PharmacyJournal of Hematology Oncology Pharmacy · Fri, 07 Aug 2026 16:18:45 GMTHow to Ask for Help if You Have HR+/HER2- Metastatic Breast Cancer - Everyday HealthEveryday Health · Fri, 07 Aug 2026 15:28:29 GMTPreclinical study shows technology could slow aggressive breast cancer - Spectrum News 13Spectrum News 13 · Thu, 06 Aug 2026 15:20:00 GMTWearable electric-field device slows aggressive breast cancer in preclinical study - Medical XpressMedical Xpress · Thu, 06 Aug 2026 11:00:04 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTDatroway Wins EU Approval for First-Line Metastatic Triple-Negative Breast Cancer - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 17:17:31 GMT7 New Breakthroughs for Triple-Negative Breast Cancer - Breast Cancer.orgBreast Cancer.org · Wed, 29 Jul 2026 07:00:00 GMT